GHK-Cu vs Glutathione
GHK-Cu is the copper(II) complex of glycyl-L-histidyl-L-lysine, an endogenous human plasma tripeptide studied for collagen synthesis, extracellular matrix remodelling and wound repair. Glutathione is the endogenous tripeptide of glutamate, cysteine and glycine that serves as the principal intracellular thiol antioxidant, and in dermatology it is studied mainly for skin pigmentation. Both are tripeptides, both are sold for skin, and vendor pages routinely present them as a clean complementary pair. The published record contains something more specific and less convenient. Several papers have combined the two directly, but none of them measured cosmetic outcomes: they are inorganic chemistry and permeation studies, and the most detailed of them reports that reduced glutathione, the strongest reductant in human plasma, reduces the copper(II) complex to which GHK-Cu's activity is attributed. No study has compared the two for collagen, wrinkles, pigmentation or any other clinical endpoint.
They have been compared directly.
Five located studies applied both compounds within a single experiment, and all are chemistry, permeation or delivery work rather than efficacy comparisons. The most detailed is a 2021 inorganic chemistry study that reacted Cu(II)GHK with reduced glutathione and characterised the reaction by ultraviolet-visible and circular dichroism spectroscopy, electron paramagnetic resonance, nuclear magnetic resonance and cyclic voltammetry. It identified a transient GSH-Cu(II)GHK complex as an intermediate and concluded that glutathione reduces the copper in GHK-Cu to Cu(I), with the rate tuned by ternary ligands, proposing the complex as a precursor for copper acquisition by the CTR1 transporter. An older 1989 electron spin resonance study, using a narrower technique set, reported that CuGHK formed no detectable adduct on addition of glutathione and read that as consistent with poor cellular uptake of CuGHK. A 2008 permeation study compared GHK-Cu and GSH-Cu through a liposome membrane in a Franz diffusion cell and found that both complexes permeated a model of the horny lipid layer, with the peptide influencing the dynamics of copper ion diffusion. A 2018 study measured the radical-scavenging profile of GHK directly against reduced glutathione and carnosine by electron spin resonance spin trapping, and reported that GHK's effect on the hydroxyl radical signal was stronger than that of either comparator. A 2026 materials paper used glutathione as the redox trigger releasing GHK from a disulfide-linked dermal carrier. Taken together, the direct evidence describes a chemical interaction between the two molecules and their relative behaviour in model systems, not a comparison of what either does to skin.
The 15 studies that tested both
- 01In vitro2021
Intermediate Cu(II)-Thiolate Species in the Reduction of Cu(II)GHK by Glutathione: A Handy Chelate for Biological Cu(II) Reduction
Ufnalska I, Drew SC, Zhukov I, et al. · Inorganic Chemistry · solution chemistry of Cu(II)GHK reacted with reduced glutathione, characterised by ultraviolet-visible and circular dichroism spectroscopy, electron paramagnetic resonance, nuclear magnetic resonance and cyclic voltammetry, with temperature, glutathione concentration, oxygen access and ternary ligands varied
Reduced glutathione, described by the authors as the strongest reductant naturally occurring in human plasma, reduced the copper in Cu(II)GHK. A transient GSH-Cu(II)GHK complex was identified as the key reaction intermediate, and its reduction rate was tunable by ternary ligands. The authors proposed that this complex could act as a precursor of Cu(I) ions for acquisition by the CTR1 cellular copper transporter.
- 02In vitro1989
ESR studies of the interaction of copper(II)GHK, histidine, and Ehrlich cells
Antholine WE, Petering DH, Pickart L · Journal of Inorganic Biochemistry · electron spin resonance spectroscopy of the tridentate CuGHK complex on addition of glutathione, histidine, or Ehrlich ascites tumour cells
CuGHK formed no electron spin resonance-detectable adducts on addition of either glutathione or Ehrlich ascites cells under the conditions used, which the authors read as consistent with poor cellular uptake of CuGHK. Adduct formation was detected with histidine, but the CuGHK-histidine adduct was not stable in the presence of the tumour cells, and the authors argued a Cu(His)2 complex forms instead. The negative glutathione result predates the 2021 study that used a wider technique set.
- 03In vitro2008
Biological activities of selected peptides: skin penetration ability of copper complexes with peptides
Mazurowska L, Mojski M · Journal of Cosmetic Science · Franz diffusion cell with a liposome membrane of liquid crystalline systems modelling the intercellular cement of the stratum corneum; penetration of GHK-Cu and GSH-Cu compared
Both copper complexes permeated membranes modelling the horny lipid layer, and the identity of the peptide influenced the dynamics of copper ion diffusion. This is the only located study that placed GHK-Cu and a glutathione-copper complex side by side in the same permeation model, and it addressed transport through a synthetic barrier rather than delivery into human skin.
- 04In vitro2018
The peptide glycyl-L-histidyl-L-lysine is an endogenous antioxidant in living organisms, possibly by diminishing hydroxyl and peroxyl radicals
Sakuma S, Ishimura M, Yuba Y, et al. · International Journal of Physiology, Pathophysiology and Pharmacology · flow cytometry of reactive oxygen species in Caco-2 cells with an oxidation-sensitive fluorescent dye, plus electron spin resonance spin trapping of hydroxyl, superoxide and peroxyl radicals; GHK compared against reduced glutathione and carnosine
GHK reduced the tert-butyl hydroperoxide-induced rise in reactive oxygen species in Caco-2 cells at low micromolar concentrations. Spin trapping showed that GHK diminished hydroxyl and peroxyl radical signals but not superoxide, and that its effect on the hydroxyl radical signal was stronger than that of reduced glutathione or carnosine. The comparison was made on isolated radical species in a chemical system, not on skin.
- 05In vitro2026
Redox-Responsive GHK-Conjugated Sponge Spicules for Sustained Dermal Delivery and Enhanced Collagen Synthesis
Hong WK, Huang PP, Duncan D, et al. · Micromachines · thiol-functionalised sponge spicule composite with GHK covalently conjugated by disulfide linkage; release testing with and without reduced glutathione, plus a bioprinted artificial human skin model
Peptide release was selectively accelerated by reduced glutathione through disulfide bond cleavage, reaching about 60 percent cumulative release over 35 days in the presence of glutathione compared with slower release under non-reductive conditions. In the artificial skin model the composite delivered more GHK than a physical mixture of spicules and free peptide and increased type I collagen expression, with changes associated with TGF-beta and SMAD2/3 signalling. Glutathione functioned as the release trigger rather than as a comparator.
- 06Animal in vivo2022
Glycyl-L-histidyl-L-lysine-Cu2+ attenuates cigarette smoke-induced pulmonary emphysema and inflammation by reducing oxidative stress pathway
Zhang Q, Yan L, Lu J, Zhou X · Frontiers in Molecular Biosciences · mouse model of cigarette smoke-induced pulmonary emphysema with GHK-Cu administration; oxidative stress and inflammatory readouts
GHK-Cu attenuated emphysema and lung inflammation in smoke-exposed mice, with the effect attributed to reduced oxidative stress signalling. Glutathione appeared as an oxidative stress readout in the treated tissue rather than as an administered comparator, and the model concerns lung rather than skin.
- 07In vitro2023
Differential Effects of Histidine and Histidinamide versus Cysteine and Cysteinamide on Copper Ion-Induced Oxidative Stress and Cytotoxicity in HaCaT Keratinocytes
Ha JW, Choi JY, Boo YC · Antioxidants (Basel) · 20 free and 20 amidated amino acids screened for copper chelation and for cytoprotection in HaCaT keratinocytes exposed to copper sulphate, with GHK-Cu and EDTA as reference compounds
Cysteine had the highest copper chelation activity among free amino acids and histidine the second highest, but only histidine and histidinamide prevented copper-induced keratinocyte death; cysteine and cysteinamide did not, despite potent chelation. Histidine and histidinamide suppressed copper-induced reactive oxygen species production, glutathione oxidation, lipid peroxidation and protein carbonylation. GHK-Cu, used as a reference, had no cytoprotective effect in this assay.
- 08In vitro2021
Enhanced angiogenic effects of RGD, GHK peptides and copper (II) compositions in synthetic cryogel ECM model
Zoughaib M, Luong D, Garifullin R, et al. · Materials Science and Engineering C · synthetic cryogel extracellular matrix model functionalised with RGD and GHK peptides and copper(II), with angiogenic assays
Combining GHK peptide with copper(II) in the cryogel scaffold enhanced angiogenic responses relative to the peptide or metal alone. Glutathione featured only in the redox context of the scaffold chemistry, not as an administered agent.
- 09Animal in vivo2020
Expression and Purification of Recombinant GHK Tripeptides Are Able to Protect against Acute Cardiotoxicity from Exposure to Waterborne-Copper in Zebrafish
Hsiao CD, Wu HH, Malhotra N, et al. · Biomolecules · zebrafish exposed to waterborne copper with recombinant GHK tripeptide, cardiac function and oxidative stress endpoints
Recombinant GHK protected zebrafish against acute cardiotoxicity from waterborne copper exposure. Glutathione was measured as an oxidative stress marker in the exposed animals rather than being supplied, and the model addresses copper toxicity rather than any dermatological endpoint.
- 10In vitro2024
Evaluation of GHK peptide-heparin interactions in multifunctional liposomal covering
Nikolaeva V, Kamalov M, Abdullin TI, et al. · Journal of Liposome Research · physicochemical characterisation of GHK peptide interactions with heparin within a multifunctional liposomal coating
The study characterised how GHK associates with heparin in a liposomal delivery system and how that affects the coating's properties. Glutathione appeared in the redox background of the formulation chemistry rather than as a test article, and no biological comparison with GHK-Cu was made.
- 11In vitro2021
Protective and Anti-Aging Effects of 5 Cosmeceutical Peptide Mixtures on Hydrogen Peroxide-Induced Premature Senescence in Human Skin Fibroblasts
Wu Y, Cao K, Zhang W, et al. · Skin Pharmacology and Physiology · hydrogen peroxide-induced premature senescence in human skin fibroblasts treated with five cosmeceutical peptide mixtures, one containing GHK
The peptide mixtures reduced markers of hydrogen peroxide-induced premature senescence in cultured fibroblasts. Glutathione was one of the antioxidant readouts used to characterise the response, and because the test articles were mixtures the contribution of GHK specifically was not isolated.
- 12Animal in vivo2007
A therapeutic approach for diabetic wound healing using biotinylated GHK incorporated collagen matrices
Arul V, Kartha R, Jayakumar R · Life Sciences · biotinylated GHK incorporated into collagen matrices and applied to wounds in a diabetic animal model, with tissue biochemistry
Collagen matrices carrying biotinylated GHK improved wound repair parameters in the diabetic model relative to untreated matrices. Tissue glutathione was among the antioxidant measures used to characterise the healing environment rather than an administered comparator.
- 13Review2025
Exploring the Role of Tripeptides in Wound Healing and Skin Regeneration: A Comprehensive Review
Adnan SB, Maarof M, Fauzi MB, Fadilah NIM · International Journal of Medical Sciences · comprehensive review of tripeptides in wound healing and skin regeneration covering studies published between 2016 and 2025
The review treated GHK and glutathione as members of the same tripeptide class but assigned them different roles: GHK-based formulations including nanoparticle conjugates, hydrogels and clinical derivatives were described as enhancing fibroblast migration, extracellular matrix remodelling, collagen and elastin synthesis and wound closure, while glutathione was discussed for antibacterial activity against carbapenem-resistant isolates and synergy with meropenem. No comparative experiment between the two was described.
- 14Review2026
Integrative Dermatology for Longevity: The Synergy of Topical and Internal Approaches
Haykal D, Flament F, Balooch G, et al. · Dermatologic Therapy (Heidelberg) · narrative review of an integrative topical and internal model for skin longevity, covering retinoids, peptides, antioxidants and exosome formulations alongside nutraceuticals
The review placed peptides such as GHK among topical interventions and glutathione among internal nutraceuticals, describing the latter as used for detoxification, melanogenesis and skin radiance and citing the narrative review that flagged safety concerns for its supplementation. The framing separates the two by route rather than testing them against each other.
- 15Case report2025
Accelerated Resolution of Pacemaker Pocket Hematoma With Adjunctive Phototherapy: A Case Report
Kneller JR · Cureus · single patient case report of adjunctive phototherapy applied to a pacemaker pocket haematoma
The report described accelerated resolution of the haematoma in one patient and attributed the proposed mechanism partly to elevation of endogenous GHK by the phototherapy patch, with glutathione mentioned incidentally in the redox rationale. A single uncontrolled case with an indirect mechanism carries minimal evidentiary weight for either compound.
Side by side.
| GHK-Cu | Glutathione | |
|---|---|---|
| Evidence maturity | Early clinical | Early clinical |
| Studies cited here | 15 | 15 |
| Published 2023 or later | 10 | 9 |
| Newest paper | 2026 | 2026 |
| Sequence and origin | Glycyl-L-histidyl-L-lysine complexed with copper(II). GHK is an endogenous constituent of human plasma that binds copper with high affinity, and a GHK triplet occurs within the alpha-2(I) chain of type I collagen, which has been proposed as its endogenous source. | Gamma-glutamyl-cysteinyl-glycine, synthesised in every cell and present intracellularly at millimolar concentration. It carries no metal and its synthesis is normally limited by cysteine availability. |
| Mechanism as described in the literature | Attributed to the copper-complexed form. In cell culture it increases fibroblast collagen and glycosaminoglycan synthesis at picomolar to nanomolar concentrations, and gene-expression work reports broad modulation of extracellular matrix, antioxidant and inflammatory programmes. | Acts as the principal intracellular thiol antioxidant and redox buffer, as substrate for glutathione peroxidases and glutathione S-transferases, and in dermatology as an inhibitor of melanogenesis. It is regenerated from its oxidised form by glutathione reductase. |
| How the two interact chemically | Its copper(II) centre is the reactive point. A 2021 study established that reduced glutathione reduces Cu(II)GHK to Cu(I) through a transient GSH-Cu(II)GHK intermediate, which cuts against the assumption of a chemically inert pairing. | It is the strongest reductant naturally occurring in human plasma, which is precisely why it reduces the copper complex. A 2026 delivery study exploited the same reducing power, using glutathione to cleave a disulfide bond and release GHK from a dermal carrier. |
| Size of the evidence base | Fifteen studies in the research entry for this compound, of which six are human clinical and one is a systematic review, with ten published in 2023 or later. A 2026 PRISMA review screening the literature from database inception identified only 20 eligible studies of GHK-Cu as a standalone aesthetic intervention, 18 preclinical and 2 randomised controlled trials. | Fifteen studies in the research entry for this compound, of which ten are human clinical and two are systematic reviews, with nine published in 2023 or later. Randomised trial evidence exists across pharmacokinetics, dermatology and precursor repletion. |
| Best-characterised finding | Stimulation of collagen synthesis in cultured fibroblasts across a picomolar to nanomolar dose-response, first reported in 1988, independent of any change in cell number. | Repeated oral dosing raises body glutathione stores. A 6-month randomised placebo-controlled trial in 54 non-smoking adults reported increases of about 30 to 35 percent in erythrocytes, plasma and lymphocytes, returning to baseline after a one-month washout. |
| Human data | Present but thin and inconsistent. The two largest randomised trials of topical copper tripeptide, in venous stasis ulcers with 86 evaluable patients in 1992 and on CO2 laser-resurfaced skin with 13 completers in 2006, found no significant benefit on objective endpoints. Most positive human reports come from uncontrolled studies of multi-ingredient formulations. | More substantial in dermatology. A 2025 systematic review identified five randomised controlled trials of oral glutathione reporting significant reductions in melanin index versus placebo, with combined topical plus oral outperforming monotherapy, although roughly half the included studies carried a high risk of bias. |
| Safety signals reported | No serious adverse events reported in the small controlled trials. Copper chemistry is the theoretical concern rather than a documented harm, and the 2023 keratinocyte study found GHK-Cu was not cytoprotective against copper-induced cell death in that assay. | Oral use has been well tolerated for up to six months. Intravenous glutathione has been linked in review literature to anaphylaxis and hepatotoxicity, and one participant in an intranasal Parkinson's disease trial developed cardiomyopathy. |
| Regulatory status | Used as a cosmetic ingredient under names including copper tripeptide-1; no approved pharmaceutical formulation in any jurisdiction, and a 2026 systematic review noted an absence of standardised clinical guidelines despite growing aesthetic use. | Not an approved treatment for skin lightening, anti-ageing or general wellness in any major jurisdiction. A 2026 critical review classified intravenous longevity therapy including glutathione infusion as experimental rather than evidence-based. |
And what it does not.
Papers combining these two compounds do exist, but they answer a different question from the one comparison pages ask. The strongest of them is inorganic chemistry: reduced glutathione, the most abundant strong reductant in human plasma, reduces the Cu(II) in GHK-Cu through a transient mixed complex. That is a real interaction, and it sits awkwardly beside the standard framing of a clean complementary stack, since GHK-Cu's reported activity is attributed to the copper-complexed form. It is also not evidence of harm, benefit or antagonism in skin, because none of these experiments used skin as an endpoint. On efficacy the two evidence bases point in different directions rather than competing. GHK-Cu has decades of in vitro collagen and gene-expression data and a small set of controlled human trials, the two largest of which were negative on objective endpoints, and its permeation from cosmetic vehicles is poorly characterised. Glutathione has more human randomised evidence, concentrated in pigmentation, where a 2025 systematic review found consistent melanin index reductions with oral dosing but flagged a high risk of bias in about half the studies. Neither compound has controlled evidence for the outcome most often claimed for the other.
Common questions.
- Does glutathione interfere with GHK-Cu?
In solution chemistry it changes it. A 2021 inorganic chemistry study reacted Cu(II)GHK with reduced glutathione and found that glutathione reduces the copper(II) centre to Cu(I) through a transient GSH-Cu(II)GHK intermediate, with the rate tunable by other ligands present. The authors framed this as a plausible route for copper trafficking to the CTR1 transporter rather than as inactivation. Whether the same reaction meaningfully affects a topically applied product has not been studied, so the finding describes chemistry in a controlled system, not an outcome in skin.
- Has either compound been tested for the effect claimed for the other?
Not in a controlled trial. GHK-Cu has no published randomised trial of pigmentation or melanin index, which is where glutathione's dermatological evidence sits. Glutathione has no published trial of collagen synthesis, wrinkle depth or extracellular matrix remodelling in humans, which is where GHK-Cu's mechanistic literature sits. The absence of overlap is why no head-to-head efficacy comparison exists: the two are studied for different endpoints in different study designs.
- Do the two contradictory chemistry papers cancel each other out?
They are not equivalent. The 1989 electron spin resonance study reported that CuGHK formed no detectable adduct when glutathione was added and read that as consistent with poor cellular uptake. The 2021 study used ultraviolet-visible and circular dichroism spectroscopy, electron paramagnetic resonance, nuclear magnetic resonance and cyclic voltammetry together and characterised a transient intermediate that a single technique would be unlikely to capture, while also varying temperature, oxygen access and ternary ligands. The later work is the more complete characterisation, and the earlier negative result is best read as a limitation of the method rather than as a refutation.
- Are both compounds tripeptides in any meaningful sense?
Both are three-residue peptides, and a 2025 review of tripeptides in wound healing covers both, but the similarity ends at chain length. GHK carries a histidine-lysine motif that binds copper with high affinity, and its reported activity is attributed to the metal complex rather than to the free peptide. Glutathione contains a cysteine thiol and an unusual gamma-linked glutamate that resists ordinary peptidases, and its function is thiol redox chemistry with no metal centre. The shared classification does not imply shared mechanism.
- Which has the better-characterised delivery into skin?
Neither is well characterised, but the gaps differ. For GHK-Cu, a 2025 review concluded that published information on skin permeability and physicochemical behaviour remains insufficient despite widespread use in marketed anti-wrinkle products, and no dose-response for a topical effect has been established in humans. For glutathione the question has mostly been asked about systemic rather than dermal delivery, and randomised crossover work published in 2026 found that micellar, liposomal and orally dissolving film preparations produced markedly different systemic exposure from standard oral glutathione.
For research purposes only. Not for human consumption, diagnosis, treatment, or prevention of any condition. Nothing on this page is medical advice, and no comparison here should be read as a recommendation of either compound.